StemCor Systems has received a National Institutes of Health Phase I Small Business Innovation Research Grant to further develop the MarrowMiner, which recently received 510(k) clearance from the FDA for harvesting bone marrow.
Subscribe to our email newsletter
Vartan Ghazarossian, president and CEO of StemCor, said: “The grant will be used to broaden our capabilities regarding the harvest of bone marrow, as well as the processing of stem and progenitor cells it contains, for bone marrow transplantation. Additionally, the MarrowMiner System has the potential to improve upon a growing number of therapeutic applications in the field of Regenerative Medicine including cardiovascular, neurologic, diabetic and orthopedic disorders.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.